^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    autologous Tcm cellular immunotherapy

    i
    Associations
    News

    Trials

    Company:
    Newish Technology
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Autologous Tcm Cells Immunotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC) (NCT03432156)
    Phase 2
    Beijing Friendship Hospital
    Unknown status
    Last update posted :
    12/19/2018
    Initiation :
    04/03/2018
    Primary completion :
    12/01/2019
    Completion :
    12/01/2020
    CEACAM5 • MUC16 • KRT19
    |
    autologous Tcm cellular immunotherapy